E
Eias Kassem
Researcher at Hillel Yaffe Medical Center
Publications - 33
Citations - 358
Eias Kassem is an academic researcher from Hillel Yaffe Medical Center. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 11, co-authored 29 publications receiving 252 citations.
Papers
More filters
Journal ArticleDOI
Paracetamol treatment of patent ductus arteriosus in preterm infants.
TL;DR: It is proposed that paracetamol could contribute to the closure of PDA in preterm infants and it is possible that PDA may have closed spontaneously later.
Journal ArticleDOI
Involvement of main diarrheagenic Escherichia coli, with emphasis on enteroaggregative E. coli, in severe non-epidemic pediatric diarrhea in a high-income country.
Joshua Tobias,Eias Kassem,Uri Rubinstein,Anya Bialik,Sreekanth-Reddy Vutukuru,Armando Navaro,Assaf Rokney,Lea Valinsky,Moshe Ephros,Dani Cohen,Khitam Muhsen +10 more
TL;DR: DEC was common in this pediatric population, in a high-income country, and mixed EAEC and rotavirus infection was characterized by especially severe diarrhea.
Journal ArticleDOI
Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.
Khitam Muhsen,Emilia Anis,Uri Rubinstein,Eias Kassem,Sophy Goren,Lester M. Shulman,Lester M. Shulman,Moshe Ephros,Daniel Cohen +8 more
TL;DR: High effectiveness of RotaTeq as the sole rotavirus vaccine in a universal immunization programme was demonstrated in a high-income country and, although partial vaccination conferred protection, completing the vaccine series is warranted to maximize the benefit.
Journal ArticleDOI
ACTN3 Polymorphism: Comparison Between Elite Swimmers and Runners
TL;DR: Compared allelic and genotype frequencies of the ACTN3 R577X polymorphism among runners and swimmers specializing in different distances, and >non-athletic controls, suggest that it cannot differentiate significantly between SDS and LDS.
Journal ArticleDOI
A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel
Khitam Muhsen,Uri Rubenstein,Eias Kassem,Sophy Goren,Yaakov Schachter,Adi Kremer,Lester M. Shulman,Moshe Ephros,Dani Cohen +8 more
TL;DR: Hospitalizations due to rotavirus gastroenteritis in children <5 years of age decreased significantly, by 55% (95% CI 43%-67%) during the period of universal vaccination (2011–2013), a decrease that was sustained throughout the 3 year period.